The Evolution of the Management of Dysplasia in Ulcerative Colitis
Cancers · 04.04.2026 · 18 (7) · 1165
DOI: 10.3390/cancers18071165 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.04.2026. Verfasst von Adrienne L Vickers und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Weill Cornell Medicine, NewYork-Presbyterian, 1300 York Avenue, New York, NY 10065, USA. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
With modern medicine and a better understanding of the ulcerative colitis disease process, there have been many changes in how we manage ulcerative colitis-related dysplasia over the past 20 years. One of the biggest concerns for these patients, given the inflammatory nature of their disease, is the progression from chronic inflammation to cancer. Patients with ulcerative colitis have about a 2.4-fold increased risk of developing colorectal cancer compared to the general population, which is concerning since colorectal cancer is the 2nd leading cause of cancer-related deaths in the United States. Traditionally, surgery was the preferred treatment for ulcerative colitis patients with dysplasia, but now, with advances in surveillance such as high-definition colonoscopy and chromoendoscopy, the management approach is more nuanced. Understanding the risk for different individuals within this patient population is key to comprehensive and personalized care management. In this review article, we will explore risk factors, surveillance methods, and classification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Weill Cornell Medicine, NewYork-Presbyterian, 1300 York Avenue, New York, NY 10065, USA.
- Section of Colon and Rectal Surgery, Department of Surgery, Weill Cornell Medicine, NewYork-Presbyterian, 1300 York Avenue, New York, NY 10065, USA.
ORCID-Profile: Alessandro Fichera
Zitieren
APA
Vickers, A. L., & Fichera, A. (2026). The Evolution of the Management of Dysplasia in Ulcerative Colitis. Cancers, 18(7), 1165. https://doi.org/10.3390/cancers18071165
Vancouver
Vickers AL, Fichera A. The Evolution of the Management of Dysplasia in Ulcerative Colitis. Cancers. 2026;18(7):1165. doi:10.3390/cancers18071165
BibTeX
@article{Vickers2026,
author = {Vickers, Adrienne L and Fichera, Alessandro},
title = {The Evolution of the Management of Dysplasia in Ulcerative Colitis},
journal = {Cancers},
year = {2026},
volume = {18},
number = {7},
pages = {1165},
doi = {10.3390/cancers18071165}
}
EUVIMED